Three-Drug attack aims to make inoperable stomach cancer operable
NCT ID NCT07194005
Summary
This study tests whether a combination of three drugs can shrink advanced stomach tumors that are currently inoperable, with the goal of making surgery possible. It is for patients whose cancer has a specific protein marker (HER2 1+/2+). The main measure of success is whether the treatment shrinks the tumor enough for surgeons to remove it completely with clear margins.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GASTRIC CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Fudan University Shanghai Cancer Center
RECRUITINGShanghai, Shanghai Municipality, 200230, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.